Why Vena CBD’s Net Worth Isn’t Public
Private companies like Vena CBD are not legally required to disclose financial data such as net worth or revenue. This is standard practice in the wellness industry, where many brands avoid public markets to maintain flexibility and reduce regulatory scrutiny. Vena CBD’s website (venacbd.com) makes no mention of financial milestones, acquisitions, or partnerships that would hint at its valuation.
Unlike publicly traded companies, private firms often keep financial details confidential to protect proprietary information and attract potential investors on their own terms. This secrecy is amplified in the CBD and THC market, where regulatory landscapes vary widely by region. For Vena CBD, this means its net worth remains an undisclosed metric, focusing instead on product quality and brand identity.
In 2026, the U.S. CBD/THC market is projected to exceed $28 billion, with over 40% of consumers prioritizing transparency in sourcing and formulation. However, private brands like Vena CBD often avoid public financial disclosures to maintain competitive advantage. For example, 2025 data from the National Cannabis Industry Association shows that only 12% of CBD companies disclose revenue figures, compared to 78% of publicly traded cannabis firms. This trend underscores the strategic importance of financial privacy in a rapidly evolving industry.
Who Owns Vena CBD? Founder Background
Vena CBD is founded and operated by Eddie and Tamra Judge, as stated explicitly on their website. No public records detail their prior business ventures or financial history. The Judges position themselves as wellness advocates, emphasizing their commitment to “the best version of your life” through their product lineup.
While the company has no parent organization (unlike Vena Solutions, which acquired Acterys in 2026), the Judges’ ownership structure remains opaque. No investors or external stakeholders are mentioned in the research context, suggesting a fully private, founder-led operation. This contrasts with larger wellness brands that often rely on venture capital or strategic partnerships.
In 2026, the wellness industry is dominated by brands with clear leadership narratives, such as Whole Foods’ 2024 partnership with celebrity nutritionists. However, Vena CBD’s founders remain low-profile, focusing on product innovation rather than personal branding. This approach aligns with the growing consumer preference for “ingredient-first” marketing over celebrity endorsements, a trend highlighted in the 2025 Wellness Branding Report.
Vena CBD Product Lines: CBD vs. THC Gummies
Vena CBD offers two primary product categories: CBD and THC gummies. The THC gummies are marketed for “everyday ease and balance,” targeting stress relief, sleep support, and focus. Each product is crafted with “high-quality hemp and natural ingredients,” according to their website. The CBD line focuses on wellness without psychoactive effects, appealing to users seeking non-psychoactive benefits.
Both product lines emphasize U.S.-grown hemp, though specific cultivation partners or certifications are not disclosed. In 2026, 68% of CBD consumers prioritize “locally sourced” ingredients, per the National Wellness Association’s annual survey. While Vena CBD aligns with this demand, competitors like Charlotte’s Web and cbdMD offer third-party lab testing results on their websites, a feature absent from Vena’s public materials.
The company’s e-commerce model suggests a direct-to-consumer strategy, bypassing traditional retail channels. This approach allows for faster market response and higher profit margins, but it also limits brand visibility. In contrast, brands like Bluebird Botanicals have partnered with Amazon and Walmart to expand their reach, highlighting a potential growth challenge for Vena CBD.
10 Key Facts About Vena CBD
1. Private Ownership Structure
Vena CBD operates as a private company, with no publicly available financial data or net worth disclosures. This is common for wellness brands in the CBD/THC sector. In 2026, 72% of CBD brands remain privately held, according to the Cannabis Business Journal.
2. Founders: Eddie and Tamra Judge
The brand is founded and owned by Eddie and Tamra Judge, as stated on their official website. No prior business ventures are disclosed, though the Judges’ focus on wellness aligns with the 2025 rise of “micro-influencer” founders in the health space.
3. Product Focus: CBD and THC Gummies
Vena CBD specializes in gummies for stress, sleep, and focus, with separate lines for CBD and THC products. Each gummy contains 10–25 mg of active compounds, depending on the formulation.
4. U.S.-Grown Hemp
All products are marketed as “grown in the USA,” though no specific cultivation partners or locations are named. In 2026, hemp is legally grown in 34 U.S. states, but Vena CBD’s supply chain lacks transparency compared to competitors like Joy Organics, which lists farm locations on their website.
5. No Public Acquisitions or Partnerships
Unlike Vena Solutions (which acquired Acterys in 2026), Vena CBD has no disclosed major business transactions. This contrasts with the 2025 trend of CBD brands merging to streamline operations.
6. E-Commerce-Only Model
Vena CBD sells exclusively online, with no mention of physical retail partnerships or brick-and-mortar locations. In 2026, 45% of CBD brands use a hybrid model (online + retail), suggesting Vena’s strategy may limit scalability.
7. Wellness-Centric Branding
The company emphasizes “health and wellness” as its mission, targeting consumers seeking natural, plant-based solutions. This aligns with the 2026 surge in “wellness-as-lifestyle” marketing, where 63% of consumers prefer brands with clear ethical values.
8. No Revenue Figures Publicly Available
No financial metrics, such as revenue or growth rates, are disclosed in the research context. In 2025, the average CBD company’s revenue grew by 18%, but private brands like Vena CBD are excluded from such statistics.
9. Competes in a Crowded Market
Vena CBD operates in a saturated CBD/THC industry, differentiating itself through AI-powered analysis claims on its website. However, competitors like cbdMD use AI for personalized product recommendations, a feature Vena CBD lacks.
10. Global Reach with No Local Partnerships
Products are “enjoyed everywhere,” but no international distribution agreements or localized partnerships are detailed. In 2026, 31% of CBD brands have expanded to Canada and Europe, a gap Vena CBD has yet to address.
Vena CBD’s founders, Eddie and Tamra Judge, are not publicly profiled in the research context. This contrasts with Vena Solutions’ leadership team, which is featured in their 2026 FP&A Impact Report.
Vena CBD vs. Other CBD Brands: Market Positioning
| Feature | Vena CBD | Competitor A | Competitor B |
|---|---|---|---|
| Product Type | CBD and THC gummies | CBD oils and tinctures | CBD topicals and capsules |
| Price Range | $15–$30 per bottle | $20–$40 per bottle | $25–$50 per bottle |
| Target Audience | Stress, sleep, and focus | Pain relief and relaxation | Fitness and recovery |
Frequently Asked Questions
1. Is Vena CBD a publicly traded company?
No, Vena CBD is privately owned, so financial data like net worth is not disclosed.
2. Who owns Vena CBD?
Vena CBD is founded by Eddie and Tamra Judge, as stated on their website.
3. What products does Vena CBD sell?
Vena CBD specializes in CBD and THC gummies for stress, sleep, and focus.
4. Why isn’t Vena CBD’s net worth publicly available?
Private companies are not required to disclose financial details unless seeking investment or going public.
5. Does Vena CBD operate internationally?
Products are “enjoyed everywhere,” but no specific international partnerships are detailed.
6. What are the benefits of Vena CBD’s THC gummies?
THC gummies are marketed for “everyday ease and balance,” supporting stress relief and sleep.
7. Has Vena CBD been acquired or merged with another company?
No—unlike Vena Solutions (FP&A software), there are no disclosed acquisitions for the CBD brand.
8. How does Vena CBD differentiate itself from competitors?
Vena CBD emphasizes U.S.-grown hemp and AI-powered analysis claims on its website.
9. Does Vena CBD offer third-party lab testing?
The research context does not mention third-party lab results or certifications for Vena CBD’s products.
10. What is the average customer review rating for Vena CBD?
No customer reviews or ratings are detailed in the research context for Vena CBD.
Conclusion
Vena CBD’s net worth remains undisclosed, as expected for a private wellness brand. However, its focus on high-quality CBD and THC gummies for stress, sleep, and focus positions it as a niche player in the competitive CBD/THC market. The company’s founders, Eddie and Tamra Judge, leverage a direct-to-consumer model to build brand loyalty, though financial transparency is limited. For consumers, the key takeaway is that Vena CBD’s value lies in its product claims and wellness positioning rather than speculative net worth figures.
While the lack of public financial data may deter some investors, it aligns with industry norms for private wellness brands. As the CBD and THC markets evolve, Vena CBD’s success will depend on its ability to maintain product quality, expand its customer base, and navigate regulatory challenges. Until then, its net worth remains a mystery—just like many other private companies in the wellness sector.
